Register for email alerts and news feeds:
This journal | BMJ Group
rss
British Journal of Ophthalmology 1999;83:814-821; doi:10.1136/bjo.83.7.814
Copyright © 1999 by the BMJ Publishing Group Ltd.
Br J Ophthalmol 1999;83:814-821 ( July )

Risk factors for failures of trabeculectomies performed without antimetabolites

Holger Mietz, Birgit Raschka, Günter K Krieglstein

Department of Ophthalmology, University of Cologne, Cologne, Germany

Correspondence to: H Mietz, MD, Department of Ophthalmology, University of Cologne, 50924 Koeln, Germany.

Accepted for publication 1 March 1999

AIMS---To assess the risk profile for the failure of trabeculectomies in a large group of patients who were selected to be operated on without the use of antimetabolites. This was done in an effort to find subgroups of patients who may not need antimetabolites for primary procedures.
METHODS---Consecutive patients scheduled for routine trabeculectomies were operated during a 4 year period and were followed up for at least 6 months postoperatively. Patients were regularly examined in the glaucoma unit and by their local ophthalmologists. Pre- and postoperative data were evaluated and success rates determined.
RESULTS---709 eyes of 566 patients were operated on; 534 eyes of 534 patients (94.4%) were finally evaluated. The mean follow up was 27.9 (SD 13.6) months with a range of 6-62 months. Success rates for complete surgical success ranged from 59% in the best group with pigmentary dispersion syndrome to 0% in the worst group with neovascular glaucoma. Success rates of patients with POAG, pseudoexfoliation, chronic angle closure, pigmentary dispersion syndrome, and dysgenetic glaucoma were similar. Failure rates ranged from 11% in the best group (pseudoexfoliation) to 80% in the worst group (neovascular glaucoma). Failure rates were high in complicated forms of glaucoma such as traumatic (30%), buphthalmus (40%), and uveitic (50%). For repeat trabeculectomies, the failure rate was 49% (20 of 41 eyes). The mean time until failure ranged from 2.7 months (traumatic) to 15.5 months (pigmentary dispersion syndrome) and was 4.9 months for repeat trabeculectomies.
CONCLUSION---Trabeculectomy performed in selected groups of patients has a favourable outcome without the use of antimetabolites. It may be possible to avoid antimetabolites in these groups of patients for primary procedures.


© 1999 by British Journal of Ophthalmology

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Ho, C. L., Wong, E. Y. M., Walton, D. S. (2004). Goniosurgery for Glaucoma Complicating Chronic Childhood Uveitis. Arch Ophthalmol 122: 838-844 [Abstract] [Full Text]  
  • Mietz, H., Jacobi, P. C., Krieglstein, G. K. (2000). Postoperative Application of Mitomycin for Trabeculectomies. Arch Ophthalmol 118: 1341-1348 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Ophthalmology Jobs

Ophthalmology Jobs